Literature DB >> 30254364

Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with KATP channels.

Umit Yasar1, Melih O Babaoglu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30254364      PMCID： PMC6461895          DOI： 10.1038/s41401-018-0088-5

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  9 in total

1.  Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Authors:  Umit Yasar; Stefan Lundgren; Erik Eliasson; Anna Bennet; Björn Wiman; Ulf de Faire; Anders Rane
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

2.  The protective effect of epoxyeicosatrienoic acids on cerebral ischemia/reperfusion injury is associated with PI3K/Akt pathway and ATP-sensitive potassium channels.

Authors:  You-Yang Qu; Mei-Yan Yuan; Yu Liu; Xing-Jun Xiao; Yu-Lan Zhu
Journal:  Neurochem Res       Date:  2014-11-04       Impact factor: 3.996

Review 3.  Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors:  Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 4.  Cytochrome P450-derived eicosanoids and heart function.

Authors:  K Lockhart Jamieson; Tomoko Endo; Ahmed M Darwesh; Victor Samokhvalov; John M Seubert
Journal:  Pharmacol Ther       Date:  2017-05-25       Impact factor: 12.310

5.  Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?

Authors:  Mustafa Tugrul Goktaş; Fazleen Hatta; Ozgur Karaca; Said Kalkisim; Levent Kilic; Ali Akdogan; Melih O Babaoglu; Atilla Bozkurt; Anders Helldén; Leif Bertilsson; Umit Yasar
Journal:  Eur J Clin Pharmacol       Date:  2015-08-02       Impact factor: 2.953

6.  Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.

Authors:  Yi-Er Qiu; Jun Qin; Yang Luo; Shao-Lan Qin; Yi-Fei Mu; Ran Cun; Hou-Li Jiang; Jian-Jun Chen; Min-Hao Yu; Ming Zhong
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-03-23       Impact factor: 3.072

7.  Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

Authors:  Umit Yasar; Anna M Bennet; Erik Eliasson; Stefan Lundgren; Björn Wiman; Ulf De Faire; Anders Rane
Journal:  Pharmacogenetics       Date:  2003-12

Review 8.  Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.

Authors:  Ann K Daly; Allan E Rettie; Douglas M Fowler; John O Miners
Journal:  J Pers Med       Date:  2017-12-28

Review 9.  The role of KATP channels in cerebral ischemic stroke and diabetes.

Authors:  Vivian Szeto; Nai-Hong Chen; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150
  9 in total
  2 in total

1.  Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes.

Authors:  Yan Li; Xi Wang; Ying Zhang
Journal:  Dis Markers       Date:  2022-03-25       Impact factor: 3.434

2.  Genetic landscape of 125 pharmacogenes in Chinese from the Chinese Millionome Database.

Authors:  Guangzhao Qi; Jingmin Zhang; Chao Han; Yubing Zhou; Duolu Li; Pengfei Ma
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.